Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Methods of Documentation V: CBE01:23

Methods of Documentation V: CBE

Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interdisciplinary training on noncommunicable diseases and sustained change in primary health care in the context of health reform, COVID-19, and war in Ukraine: A repeated qualitative study, 2016-2022.

BMC public health·2026
Same author

Potential time-sensitive biomarkers for the detection of acute mesenteric ischaemia: a systematic review of animal data.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2026
Same author

Observed practices in surgical site infection prevention in Ukraine: national survey results from 2021 and 2025.

Infection prevention in practice·2026
Same author

The impact of war on Primary Health Care in Ukraine: a cross-sectional survey and qualitative interviews with service providers.

BMC health services research·2026
Same author

The Glasgow Coma Scale as a predictor of mortality in intensive care: relevance of underlying cause of impaired consciousness.

Journal of critical care·2026
Same author

Health system response and recovery in Ukraine after 3 years of war: perspectives of front-line communities and internally displaced persons.

Health policy and planning·2026

Related Experiment Videos

The updated clinical guideline development process in Estonia is an efficient method for developing evidence-based

Lisa A Bero1, Suzanne Hill, Jarno Habicht

  • 1Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA 94118, USA. berol@pharmacy.ucsf.edu

Journal of Clinical Epidemiology
|September 15, 2012
PubMed
Summary

Estonia streamlined clinical practice guideline development by adapting existing high-quality guidelines. This efficient method addresses resource limitations, improving healthcare quality for small nations.

Related Experiment Videos

Area of Science:

  • Health Services Research
  • Evidence-Based Medicine
  • Health Policy

Background:

  • Clinical practice guidelines are crucial for enhancing healthcare quality.
  • Developing national guidelines is challenging for countries with limited resources.
  • Estonia faced variations in guideline quality and format despite initial efforts.

Purpose of the Study:

  • To revise and streamline Estonia's national clinical practice guideline development process.
  • To create an efficient method for adapting existing high-quality guidelines to the Estonian context.
  • To improve the quality and consistency of healthcare in Estonia.

Main Methods:

  • A comprehensive assessment of guideline development processes was conducted in 2010.
  • Collaboration involved the World Health Organization, Estonian Health Insurance Fund, and national/international experts.
  • The revision focused on adapting existing guidelines rather than developing new ones from scratch.

Main Results:

  • Substantial changes were made to Estonia's guideline development and implementation processes.
  • The revised process aims for efficiency and quality adaptation for the Estonian setting.
  • Harmonization of principles and processes for guideline development was a key outcome.

Conclusions:

  • Estonia successfully revised its clinical practice guideline process to overcome resource limitations.
  • The adapted guideline approach offers a model for other small or resource-limited countries.
  • Systematic quality improvement in healthcare was achieved through these process changes.